<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-viruses-12-00852">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Argaw-Denboba</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Balestrieri</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Serafino</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cipriani</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bucci</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Sorrentino</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Sciamanna</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Gambacurta</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sinibaldi-Vallebona</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Matteucci</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>HERV-K activation is strictly required to sustain CD133
   <sup>+</sup> melanoma cells with stemness features
  </article-title>
  <source>J. Exp. Clin. Cancer Res.</source>
  <year>2017</year>
  <volume>36</volume>
  <fpage>20</fpage>
  <pub-id pub-id-type="doi">10.1186/s13046-016-0485-x</pub-id>
  <pub-id pub-id-type="pmid">28125999</pub-id>
 </element-citation>
</ref>
